NR0B2 and obesity disorder: Some critical metabolic results have been obtained from Shp-null and transgenic mouse studies, which demonstrated that deletion of Shp protects animals from diet-induced obesity and hepatic steatosis and that its hepatic overexpression reverses the phenotype (10, 13, 14).